Earnings Preview For Eargo

Eargo (NASDAQ:EAR) is set to give its latest quarterly earnings report on Thursday, 2023-05-11. Here’s what investors need…

Eargo (NASDAQ:EAR) is set to give its latest quarterly earnings report on Thursday, 2023-05-11. Here’s what investors need to know before the announcement.

Analysts estimate that Eargo will report an earnings per share (EPS) of $-1.90.

Eargo bulls will hope to hear the company announce they’ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Past Earnings Performance

Last quarter the company missed EPS by $3.18, which was followed by a 10.83% drop in the share price the next day.

Here’s a look at Eargo’s past performance and the resulting price change:

Quarter Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q3 2021 Q4 2021
EPS Estimate -1 -11.2
EPS Actual -4.18 -24.2 -15.6 -15.6 -40.4 -23.2
Price Change % -10.83% -1.87% -27.01% 1.92% 0.0% 0.0%

Stock Performance

Shares of Eargo were trading at $5.31 as of May 09. Over the last 52-week period, shares are down 78.71%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.

To track all earnings releases for Eargo visit their earnings calendar on our site.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Aytu BioPharma’s Earnings: A Preview

Aytu BioPharma (NASDAQ:AYTU) is set to give its latest quarterly earnings report on Tuesday, 2022-09-27. Here's what investors need to know before the announcement. Analysts estimate that Aytu BioPharma will report an earnings per share (EPS) of $-0.37.

AYTU

Read More

Recap: Conmed Q2 Earnings

Conmed (NYSE:CNMD) reported its Q2 earnings results on Wednesday, July 27, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Conmed beat estimated earnings by 1.33%, reporting an EPS of $0.76 versus an estimate of $0.75.

CNMD